In The News

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

  • Dr. Rosalind Segal led a study that identified a protein critical to both the normal development of the brain and the development of medulloblastoma, a fast-growing brain tumor that usually strikes children younger than 10.

Tags: ChildhoodCancer

  • A patient at Dana-Farber who was treated by Dr. Keith Ligon “open-sourced” his illness by inviting friends, family, and colleagues in the field of science, to view his health information and have discussions about his treatment.


     

Tags: BrainTumors

  • Dana-Farber nutritionist Stacy Kennedy, MPH, commented on a recent survey that found many people with cancer were taking fish oil supplements despite research showing they make chemotherapy less effective.

Tags: Nutrition

  • Dr. Edward J. Benz, Jr., announced that he will retire as president and chief executive officer of Dana-Farber next summer, after 16 years.

Tags: Appointments

  • Dr. Sidney Farber – as featured in the PBS film “Cancer: The Emperor of All Maladies” – was described as an unsung hero of cancer research for his efforts in discovering the use of chemotherapy as a form of treatment for pediatric cancer patients.

Tags: chemotherapy, ChildhoodCancer

  • Sharon Bober, PhD, discussed the need for more education and frank talk about how patients can have a healthy sexual life after cancer and cancer-related surgeries.

     

Tags: OvarianCancer

  • Dr. Sidney Farber – as featured in the PBS film “Cancer: The Emperor of All Maladies” – was described as an unsung hero of cancer research for his efforts in discovering the use of chemotherapy as a form of treatment for pediatric cancer patients.

Tags: chemotherapy, ChildhoodCancer, JimmyFund

  • Dr. Judy Garber commented on actress Angelina Jolie’s decision to have her ovaries and fallopian tubes removed to help prevent cancer.

Tags: OvarianCancer

  • Dr. Edward J. Benz, Jr., was featured in the Boston Business Journal for his 15 years of service as President and CEO of Dana-Farber.

Tags: Appointments

  • Dr. Rachel Freedman led a study showing black and Hispanic women with breast cancer were less likely to pick their surgeon and the hospital for treatment based on reputation compared with white women.

Tags: BreastCancer

Showing 1-10 of 534 items